Mintu P. Turakhia, MD, MAS

Articles by Mintu P. Turakhia, MD, MAS

Anticoagulation in Atrial Fibrillation: Impact of Mental Illness

BySusan K. Schmitt, PhD,Mintu P. Turakhia, MD, MAS,Ciaran S. Phibbs, PhD,Rudolf H. Moos, PhD,Dan Berlowitz, MD, MPH,Paul Heidenreich, MD, MS,Victor Y. Chiu, MD,Alan S. Go, MD,Sarah A. Friedman, MSPH,Claire T. Than, MPH,Susan M. Frayne, MD, MPH

November 30th 2015

Atrial fibrillation patients with mental health conditions are less likely to be eligible for warfarin receipt, and those who are eligible receive warfarin at lower rates.

Latest Updated Articles

Anticoagulation in Atrial Fibrillation: Impact of Mental Illness
Published: November 30th 2015 | Updated:

Mintu P. Turakhia, MD, MAS

Articles by Mintu P. Turakhia, MD, MAS

Anticoagulation in Atrial Fibrillation: Impact of Mental Illness

Latest Updated Articles

Trending on AJMC

Advances in MASLD and MASH Care Highlight Progress and Persistent Gaps

Howard A. “Skip” Burris, III, MD: An Oncology Pioneer Reflects on Patients, Progress, and Purpose

Employer Premiums and Deductibles Consume Significant Portion of Income in 19 States

Patients With Long-Term Conditions Prefer Remote Visits for Routine Care

New Bill Makes CMS Enforcer in PBM, Pharmacy Relationship: A Q&A With Jesse Dresser, Esq